SFA
UTHR icon

Sequoia Financial Advisors’s United Therapeutics UTHR Stock Holding History

Sequoia Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
2,530
+106
+4% +$59.7K 0.01% 797
2026
Q1 		$1.44M Sell
2,424
-847
-26% -$422K 0.01% 737
2025
Q4 		$1.59M Buy
3,271
+1,487
+83% +$692K 0.01% 667
2025
Q3 		$748K Buy
1,784
+717
+67% +$241K ﹤0.01% 938
2025
Q2 		$307K Buy
1,067
+400
+60% +$120K ﹤0.01% 1254
2025
Q1 		$206K Sell
667
-186
-22% -$63.7K ﹤0.01% 1260
2024
Q4 		$301K Buy
853
+130
+18% +$47.8K ﹤0.01% 1020
2024
Q3 		$259K Buy
723
+81
+13% +$27.4K ﹤0.01% 1040
2024
Q2 		$205K Buy
+642
New +$170K ﹤0.01% 1100

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sequoia Financial Advisors's UTHR Position: Q2 2026 in Review

Sequoia Financial Advisors increased its United Therapeutics (UTHR) stake by 4.4% in Q2 2026, buying an estimated $59.7K and bringing the position to 2,530 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #797.

Sequoia Financial Advisors first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.59M in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sequoia Financial Advisors held 2,530 shares of United Therapeutics worth $1.37M as of Q2 2026.
  • Sequoia Financial Advisors bought 106 United Therapeutics shares in Q2 2026, an estimated $59.7K.
  • United Therapeutics made up 0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #797 holding.
  • Sequoia Financial Advisors first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Sequoia Financial Advisors's United Therapeutics position peaked at $1.59M in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.